Bruker Corp. Aktie
31,19 €
Deine Einschätzung
Bruker Corp. Aktie
Was spricht für und gegen Bruker Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Bruker Corp. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 1,32 % | -9,83 % | 0,60 % | -8,84 % | -23,55 % | - | - |
| Healthequity Inc. | 0,00 % | -8,97 % | -6,38 % | -11,41 % | -15,38 % | 29,41 % | 8,87 % |
| Omnicell Inc. | 1,96 % | -3,11 % | 6,12 % | 14,71 % | -19,59 % | -44,29 % | -72,39 % |
| Myriad Genetics | -0,25 % | -5,72 % | 2,93 % | -36,46 % | -23,87 % | -79,52 % | -83,19 % |
Kommentare
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
Why Bruker Stock Slumped Monday
Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the company's stock took something of a hit. Its price fell nearly 1% by the
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake
On Tuesday, Massachusetts-based Lane Generational disclosed that it sold out of Bruker (NASDAQ:BRKR), liquidating 87,607 shares for an estimated $3.6 million in the third quarter.
According to a




